CapsoVision Inc. Common Stock (CV)
Stock · NASDAQ · Health Care
$6.54as of 10/16/2026
Price chart
Active signals
CV Signal Track Record
How signals performed across all stocks →What CV's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| 200-Day Moving Average TouchActive now | 3 | -4.8% | 33% | October 8, 2026 |
| Volume Spike | 3 | -12.1% | 33% | September 23, 2026 |
| Any 20-session window (baseline) | +0.8% | 51% |
Computed by MarketWall from daily closing prices since April 17, 2026. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About CV
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as…
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Employees
- 99
- Website
- www.capsovision.com/
Fundamentals
- 1-day range
- $6.24$6.75
- Market cap
- $344.75M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- $-0.63
- Dividend yield
- —
- Beta
- -2.02
- Avg. volume
- 156.4K
How CapsoVision Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 26, 2026 · via SEC EDGAR / Finnhub
Forecasts
2 analyst ratings
CapsoVision Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- CVCapsoVision Inc. Common Stock$6.53▲ 1.24%Market cap $344.75MP/E —$4.46$15.37
- FOCLEDAP TMS S.A. American Depositary Shares$4.09▼ 0.97%Market cap $228.65MP/E —$3.99$6.4
- STXSStereotaxis Inc. Common Stock$1.01▼ 3.81%Market cap $133.19MP/E —$1.02$3.2
- VANIVivani Medical Inc. Common Stock (DE)$1.12▼ 2.61%Market cap $117.28MP/E —$0.9227$1.92
- HSDTSolana Company Class A Common Stock (DE)$2.24▼ 4.68%Market cap $98.09MP/E —$1.19$16.81
- HYPRHyperfine Inc. Class A Common Stock$0.755▼ 3.21%Market cap $97.48MP/E —$0.7536$2.22
- OMOutset Medical Inc. Common Stock$3.94▼ 3.43%Market cap $96.39MP/E —$2.84$15.94
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| CV CapsoVision Inc. Common Stock | $344.75M | — | $6.53 | ▲ 1.24% | $4.46$15.37 |
| FOCL EDAP TMS S.A. American Depositary Shares | $228.65M | — | $4.09 | ▼ 0.97% | $3.99$6.4 |
| STXS Stereotaxis Inc. Common Stock | $133.19M | — | $1.01 | ▼ 3.81% | $1.02$3.2 |
| VANI Vivani Medical Inc. Common Stock (DE) | $117.28M | — | $1.12 | ▼ 2.61% | $0.9227$1.92 |
| HSDT Solana Company Class A Common Stock (DE) | $98.09M | — | $2.24 | ▼ 4.68% | $1.19$16.81 |
| HYPR Hyperfine Inc. Class A Common Stock | $97.48M | — | $0.755 | ▼ 3.21% | $0.7536$2.22 |
| OM Outset Medical Inc. Common Stock | $96.39M | — | $3.94 | ▼ 3.43% | $2.84$15.94 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- CapsoVision Receives FDA Clearance For Its AI Highlights Reading Tool For The CapsoCam Plus Systembenzinga · 9/28/2026
- CapsoVision Announces FDA Clearance of AI Highlights for CapsoCam Plus®Yahoo · 9/28/2026
- CapsoVision Receives FDA Clearance For Its AI Highlights Reading Tool For The CapsoCam Plus SystemBenzinga · 9/28/2026
- CapsoVision Announces Offering Of 3,163,444 Shares Of Common Stock At A Price Of $5.69/Share, Net Proceeds Expected At $17.83MBenzinga · 9/18/2026
Insider Activity
Insider Actions →- Eliyahou Harari, et al. · September 18, 2026 · Buy878.7K @ $5.69
- Eliyahou Harari, et al. · September 18, 2026 · Buy878.7K @ $5.69
- Shen Ching Hang · September 15, 2026 · Buy878.7K @ $5.69
- Eliyahou Harari, et al. · July 17, 2026 · Buy61.1K @ $6.73
- Eliyahou Harari, et al. · July 8, 2026 · Buy81.3K @ $6.09
- Shields David Stanley · July 1, 2026 · Grant1.7K
- Joanne Carol Imperial · June 30, 2026 · Option Exercise2.0K @ $7.58
- Hui Ying Kuo · June 30, 2026 · Option Exercise2.0K @ $7.58
- Wen-Herng Henry King · June 30, 2026 · Option Exercise2.0K @ $7.58
- Michele Harari · June 30, 2026 · Option Exercise2.0K @ $7.58
- Chen Lung Tsai · June 30, 2026 · Option Exercise2.0K @ $7.58
- Julia S. Gouw · June 30, 2026 · Option Exercise2.0K @ $7.58
- Eliyahou Harari, et al. · June 26, 2026 · Buy13.8K @ $7.35
- Joanne Carol Imperial · June 8, 2026 · Sale1.2K @ $7.16
- Garcia David Michael · June 1, 2026 · Grant92.2K
Institutional Ownership
March 31, 2026
- Total shares held
- 3.73M
- Total value held
- $27.03M
- Institutional holders
- 47
- Unknown1.30M
- Unknown1.03M
- Unknown435.2K
- Unknown256.0K
- Unknown152.3K
- Unknown67.4K
- Unknown65.2K
- Unknown61.4K
- Unknown49.3K
- Unknown36.1K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
CapsoVision Receives FDA Clearance for AI Highlights Tool
CapsoVision has secured FDA clearance for its AI Highlights reading tool on the CapsoCam Plus system. The approval allows the company to market the feature as a medical device, potentially expanding its use in clinical settings. The clearance may enhance the product’s value proposition and support future growth.
CapsoVision Receives FDA Clearance for AI Highlights Tool. CapsoVision has secured FDA clearance for its AI Highlights reading tool on the CapsoCam Plus system. The approval allows the company to market the feature as a medical device, potentially expanding its use in clinical settings. The clearance may enhance the product’s value proposition and support future growth.